Replimune escalates layoffs to cut 224 Massachusetts jobs

After initially setting out plans to lay off dozens of workers in Massachusetts, Replimune Group is now increasing those ...
Seeking Alpha

Replimune plans layoffs as FDA rejects cancer drug

Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...
Seeking Alpha

Replimune: Second CRL May Have Sealed RP1's Fate - It's Hard To See Positives

News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...
blockonomi

Replimune (REPL) Shares Plunge 19% Following Second FDA Rejection of RP1 Melanoma Treatment

FDA issued a second complete response letter denying approval for Replimune’s RP1 melanoma immunotherapy The treatment was under review for use with Bristol Myers Squibb’s (BMY) Opdivo Regulatory ...
blockonomi

Replimune (REPL) Stock Plunges 19% Following Second FDA Rejection of Melanoma Treatment

FDA has now rejected Replimune’s melanoma immunotherapy RP1 on two separate occasions The drug was under consideration for use with Bristol Myers Squibb’s (BMY) Opdivo therapy Regulators maintained ...
GitHub

Run a window of Google Chrome in repl.it! Complete with saving cookies & local storage. No setup is required.

Please, please PLEASE don't use this to abuse repl.it or your school/workplace's filter! This is just a fun project I threw together with some neat features from ...
GitHub

AIChat: All-in-one LLM CLI Tool

AIChat is an all-in-one LLM CLI tool featuring Shell Assistant, CMD & REPL Mode, RAG, AI Tools & Agents, and More. Integrate seamlessly with over 20 leading LLM providers through a unified interface.